VYNDAMAX tafamidis 61 mg soft gelatin capsule blister pack

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 24bfbea06633510c
Product Name: VYNDAMAX tafamidis 61 mg soft gelatin capsule blister pack
Artg Id: 314813
Artg Name: VYNDAMAX tafamidis 61 mg soft gelatin capsule blister pack
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2020-03-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/44e92413a9f5f858a5493ee80cb9bacc.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/df392a6f3671b808fb2512faa0b52274.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

24bfbea06633510c

Type

Standard